Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East
Market for Clinical Decision Support (CDSS) in China is ~US$600 million by 2030 Aiyibotong has installed systems in >200 healthcare institutions in China Aiyibotong and Treatment.com AI both using proprietary artificial intelligence (AI) and Machine Learning (ML) platforms Co-marketing opportunities in China Combining Aiyibotong's CDSS with Treatment AI's Global Library of Medicine will look to create further differentiation and increased market share for Aiyibotong in the China and Far East markets VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has recently signed a Collaborative Agreement on with Beijing Aiyi Botong Information Technology Ltd Limited (“Aiyibotong”). Each organization has a focus in providing enhanced clinical decision support for both healthcare professionals and patients, using innovative technologies including AI and machine learning.» Mehr auf globenewswire.com
REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care. Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care.» Mehr auf globenewswire.com
Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care. Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care.» Mehr auf globenewswire.com
Unternehmenszahlen
| (EUR) | Sep. 2024 | |
|---|---|---|
| Umsatz | 7,30k | - |
| Bruttoeinkommen | 7,30k | - |
| Nettoeinkommen | −1,10 Mio | - |
| EBITDA | −1,10 Mio | - |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 13,77 Mio€ |
Anzahl Aktien | 48,99 Mio |
52 Wochen-Hoch/Tief | 0,83€ - 0,0429€ |
| Dividenden | Nein |
Beta | -0,62 |
KGV (PE Ratio) | −2,81 |
KGWV (PEG Ratio) | −0,12 |
KBV (PB Ratio) | 65,42 |
KUV (PS Ratio) | −757,97 |
Unternehmensprofil
Treatment.Com International Inc. bietet personalisierte Gesundheitsinformationsdienste in Kanada an. Es entwickelt auch eine mobile Anwendung für die Bewertung von Symptomen der Nutzer, um ihre gesundheitlichen Bedenken, Probleme und laufende Wellness-Management zu behandeln. Das Unternehmen bietet eine digitale Gesundheits-App, ein Bewertungsinstrument, das Einblicke in die Gesundheit bietet. Darüber hinaus bietet das Unternehmen medizinische Ausbildung, medizinische Klinik, und klinische Berater-Lösungen; und bietet Gesundheits-Informations-Ressource. Treatment.Com International Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.
| Name | Treatment.com International Aktie |
| CEO | Dr. Essam Hamza M.D. |
| Sitz | Vancouver, bc Kanada |
| Website | |
| Börsengang | |
| Mitarbeiter | 3 |
Ticker Symbole
| Börse | Symbol |
|---|---|
Pnk | TREIF |
Cnq | TRUE.CN |
Frankfurt | 939.F |
München | 939.MU |
Düsseldorf | 939.DU |
Assets entdecken
Shareholder von Treatment.com International Aktie investieren auch in folgende Assets
